ID
35149
Beskrivning
Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings; ODM derived from: https://clinicaltrials.gov/show/NCT02440854
Länk
https://clinicaltrials.gov/show/NCT02440854
Nyckelord
Versioner (1)
- 2019-02-19 2019-02-19 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
19 februari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
Afatinib | Therapeutic procedure Initiation Before Enrollment
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2987648
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C1704686
- UMLS CUI [2,3]
- C0332152
- UMLS CUI [2,4]
- C1516879
Beskrivning
Medical contraindication Investigational New Drugs
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0013230
Beskrivning
Investigational New Drugs
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013230
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
C0029921 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C2984891 (UMLS CUI [3])
C0332197 (UMLS CUI [1,2])
C2114399 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
C0087111 (UMLS CUI [2,1])
C1704686 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C1516879 (UMLS CUI [2,4])
C0013230 (UMLS CUI [1,2])